old	patient	sample	id	condition	treatment	response	group	patient_label	sample_label	exclude	path	notes	Sample name	pre- or post-Tildra treatment	Skin id #	In SI paper	Study #	Tildra response		Skin #	Box folder Name		additional sequencing files from	Awaiting Cite Seq?	link	"lead to correct place, and matches chromium library sheet? Yes"	CITE-seq (pre or post-flow antibody addition)	Cell Ranger Version	10x kit	mouse spike in?	phi-x  (skip this)	est # of cells	 mean reads/cell 	median genes per cell	RNA total reads	fraction reads in cells%	q30 bases in rna read	sequencing saturation	CR cliff/knee	reads confidently mapped to transcriptome	antibody	fraction antibody reads	fraction antibody reads usable	 antibody reads usable/cell	fraction  reads in barcodes with high umi counts	 fraction unrecognized antibody	antibody reads in cells	median umis per cell
S1-pre	P7	P7-Pre	277	PV	Pre	Partial	Non-responder	"P7 (277, 296): Non-responder"	P7 (277): Non-responder		19006-FL-37-01-02	use only 234 or 277 for final analyses/ Pre- and post-Tildrakizumab dataset	S1-pre2 (aka PV11)	pre (redo)	277	No	29813			277	19006-FL-37-01-02	good			https://ucsf.box.com/s/7pw9gvy7phuu9u7wrl2g1dw6g9wh14gj	yes	pre-flow	3.0.2	v3.1	no		"4,255"	" 28,603.00 "	"1,387"	"121,706,093"	77.3	75.2	51.3				91.8	7.4	"1,160"	0	8.2	8.2	326
S1-mid	P7	P7-Mid	296	PV	Mid	Partial	Non-responder	"P7 (277, 296): Non-responder"	P7 (296): Non-responder		19006FL-40-05-06-withADT-AH-61022	Psoriasis pre- and post-Tildrakizumab dataset	S1-post	post	296	No	29813	full		296	19006FL-40-05-06-withADT-AH-61022	good			https://ucsf.box.com/s/sqkr0bcz96ze64hsveweigqog04mxu51	yes	post-flow	3.0.2	v3.1	no		2437	" 45,469.00 "	1817	"110,807,980"	87.6	68.9	66.6				93.6	20.4	186	0	6.4	22.1	91
S2-pre	P1	P1-Pre	235	PV	Pre	Full	Responder	"P1 (235, 285): Responder"	P1 (235): Responder		19006FL-25-01-02	Psoriasis pre- and post-Tildrakizumab dataset	S2-pre (aka PV8)	pre	235	Yes				235	19006FL-25-01-02	good			https://ucsf.box.com/s/mj0f01jkkpd17u8y857c8sfa9vjjns7f	yes	post-flow	3.0.2	v3	yes		"4,355"	" 44,767.00 "	"1,546"	"194,961,242"	85	92.7	67.7				92.8	35	"3,497"	0	7.2	38.1	338
S2-mid	P1	P1-Mid	285	PV	Mid	Full	Responder	"P1 (235, 285): Responder"	P1 (285): Responder		19006FL-38-01-02-AH-613	Psoriasis pre- and post-Tildrakizumab dataset	S2-post	post	285	No	29813	partial		285	19006FL-38-01-02-AH-613	good			https://ucsf.box.com/s/72eohepfg6oxyawl9nzgnkd5lk7c01k6	yes	pre-flow	3.0.2	v3.1	no		575	" 117,838.00 "	1567	"67,757,392"	93.8	85.6	89.9				89.9	30.9	16209	0	10.1	34.7	1126
S3-pre	P2	P2-Pre	244	PV	Pre	Full	Responder	"P2 (244, 269): Responder"	P2 (244): Responder		19006FL-28-05-06-NEW	Psoriasis pre- and post-Tildrakizumab dataset	S3-pre (aka PV9)	pre	244	No	29813			244	19006FL-28-05-06-NEW	good	19006-33		https://ucsf.box.com/s/hewwzcvbzxmr38yk732l5jfdlnx5yv2m	yes	post-flow	3.0.2	v3.1	yes		"8,508"	" 23,884.00 "	"1,331"	"203,211,763"	89	86.8	52.5				90.3	24.8	"1,415"	0	9.7	27.7	135
S3-mid	P2	P2-Mid	269	PV	Mid	Full	Responder	"P2 (244, 269): Responder"	P2 (269): Responder		19006FL-35-01-02 AH	Psoriasis pre- and post-Tildrakizumab dataset	S3-post	post	269	No	29813	full		269	19006FL-35-01-02 AH	good		no cite seq	https://ucsf.box.com/s/b8z4zy8yr7zrj2zy1kimo2sjpzx1djku	yes	no cite-seq	3.0.2	v3.1	no		982	" 146,562.00 "	1783	"143,924,425"	91	79.3	88.6				NO cite-seq						
S4-pre	P3	P3-Pre	253	PV	Pre	Full	Responder	"P3 (253, 264): Responder"	P3 (253): Responder		19006FL-32-03-04	Psoriasis pre- and post-Tildrakizumab dataset	S4-pre (aka PV10)	pre	253	No	29813			253	19006FL-32-03-04	good			https://ucsf.box.com/s/e110obsx3mpukvcawn2gmtosd7hp6nw9	yes	post-flow	3.0.2	v3.1	yes		"4,367"	" 39,524.00 "	"1,260"	"172,605,667"	73.5	87	73.7				90.2	7.4	1162	0	9.8	8.3	50
S4-mid	P3	P3-Mid	264	PV	Mid	Full	Responder	"P3 (253, 264): Responder"	P3 (264): Responder		19006FL-33-01-02	note: Low Fraction Reads Confidently Mapped To Transcriptome (<30%)/Pre- and post-Tildrakizumab dataset	S4-post	post	264	No	29813	full		264	19006FL-33-01-02	good		no cite-seq	https://ucsf.box.com/s/o4f1n47flket3wx3ylycfn9hszfat6h9	yes	no cite-seq	3.0.2	v3.1	no		843	" 233,317.00 "	1687	"196,686,395"	92.7	79.1	87.5				NO cite-seq						
S5-pre	P8	P8-Pre	279	PV	Pre	Failure	Non-responder	"P8 (279, 292): Non-responder"	P8 (279): Non-responder		19006FL-37-03-04	Psoriasis pre- and post-Tildrakizumab dataset	S5-pre (aka PV12)	pre	279	No	29813			279	19006FL-37-03-04	good			https://ucsf.box.com/s/mqkeo4etlcove58a4gdsai4747us3945	yes	pre-flow	3.0.2	v3.1	no		"5,703"	" 22,565.00 "	1277	"128,691,866"	92.8	76.4	56.7				93	27.7	2363	0	7	30.1	674
S5-mid	P8	P8-Mid	292	PV	Mid	Failure	Non-responder	"P8 (279, 292): Non-responder"	P8 (292): Non-responder		19006-40-04-05-7302022-ah	Psoriasis pre- and post-Tildrakizumab dataset	S5-post	post	292 (await CITE-seq)	No	29813	failure		292	19006-40-04-05-7302022-ah			NO	https://ucsf.box.com/s/7msrzqyy2q5lbq8chv343aeijnmbgj85		pre-flow	3.0.2	v3.1	no		6315	" 29,890.00 "	1483	"188,755,387"	90.3	71.9	56.9				92.2	22.5	2998	0	7.8	24.8	761
S6-pre	P9	P9-Pre	289	PV	Pre	Failure	Non-responder	"P9 (289, 305): Non-responder"	P9 (289): Non-responder		await cite seq - skin 289 v3 AH	Psoriasis pre- and post-Tildrakizumab dataset	S6-pre (aka PV13)	pre	289 (await CITE-seq)	No	29813			289	await cite seq - skin 289 v3 AH	good		pending at admera as of 6/17/22	https://ucsf.box.com/s/xpa8blbb060p7mblcxlzvwey2f0rdo7d	yes	pre-flow	3.0.2	v3.1	no		"6,065"	" 70,416.00 "	"2,066"	"427,074,762"	93.2	92.2	76.3				pending CITE-seq						
S6-mid	P9	P9-Mid	305	PV	Mid	Failure	Non-responder	"P9 (289, 305): Non-responder"	P9 (305): Non-responder		19006FL-42-03	Psoriasis pre- and post-Tildrakizumab dataset	S6-post	post	305	No	29813	likely failure		305	19006FL-42-03	good		no cite seq	https://ucsf.box.com/s/l3a82u2z2l9rwhxr612odapaqpin36p5	yes	no cite-seq	3.0.2	v3.1	no		2575	" 70,253.00 "	"1,561"	"180,902,241"	95.3	87.3	84				NO cite-seq						
S7-pre	P4	P4-Pre	290	PV	Pre	Full	Responder	"P4 (290, 304): Responder"	P4 (290): Responder		19006FL-39-03-04	Psoriasis pre- and post-Tildrakizumab dataset	S7-pre (aka PV14)	pre	290	No	29813			290	19006FL-39-03-04	"replaced past no adt, good now"			https://ucsf.box.com/s/3zgnc2ay6v6mrtf470s271ln4vunm6cr	yes	pre-flow	3.0.2	v3.1	no		"6,734"	" 27,463.00 "	"1,342"	"184,941,496"	95.5	87	63.5				91.1	49.4	2514	0	8.9	54.8	466
S7-mid	P4	P4-Mid	304	PV	Mid	Full	Responder	"P4 (290, 304): Responder"	P4 (304): Responder		19006FL-41-02	Psoriasis pre- and post-Tildrakizumab dataset	S7-post	post	304	No	29813	full		304	19006-41-02	good		no cite seq	https://ucsf.box.com/s/sn36ie83sqwdmswzjz4eojoszz75b0d4	yes	no cite-seq	3.0.2	v3.1	no		"1,085"	" 69,825.00 "	"1,465"	"75,760,459"	92.6	86.1	85.5				NO cite-seq						
HC1	HC1	HC1	150	HC	None			HC1	HC1		19006FL-01-result brst150	Healthy controls	HC1		150	Yes				150	19006FL-01-result brst150	good			https://ucsf.box.com/s/q9drjeg0ycbv94a0d9n7u738gvrv9bc2	yes	pre-flow	3.0.2	v2	I donÕt know but no mouse cells in web summary		"4,822"	" 73,926.00 "	922	"356,474,532"	95.90%	85.3	90.6				94.30%	79.60%	7976	0	5.7	85.8	2673
HC2	HC2	HC2	154	HC	None			HC2	HC2		abd154 with ADT cr 302 rerun 4202022 AH	Healthy controls	HC2		154	Yes				154	abd154 with ADT cr 302 rerun 4202022 AH	good			https://ucsf.box.com/s/h2u9ghq12owmw78q499hhozd1pwlggm8	yes	post-flow	3.0.2	v2	I donÕt know but no mouse cells in web summary		"7,986"	" 90,808.00 "	"1,170"	"723,563,122"	93.80%	92.50%	87.3				97.60%	20.00%	2624	0	2.4	21	1806
HC3	HC3	HC3	155	HC	None			HC3	HC3		19006FL-03-01-02 no mouse 20220727	Healthy controls	HC3		155	Yes				155	190006FL-03-01-02 AH - no mouse 20220627				https://ucsf.box.com/s/ad3jmihz0p2slu7ttf6fhv1s6tkbagfi	yes	post-flow	3.0.2	v2	no		"7,097"	" 18,971.00 "	636	"134,643,848"	90.20%	81.20%	74.4				91.80%	20.80%	1497	7.9	8.2	23	761
HC4	HC4	HC4	169	HC	None			HC4	HC4		19006FL-06-02-06	Healthy controls	HC4		169	Yes				169A	19006FL-06-02-06	good			https://ucsf.box.com/s/0mvs8706jdz7fak1k1vp4jmdmw3c51bd	yes	post-flow	3.0.2	v3	I donÕt know but no mouse cells in web summary		"5,720"	" 21,634.00 "	"1,322"	"123,750,324"	93.40%	81.90%	46.8				89.90%	58.80%	5618	0	10.1	66.2	989
HC5	HC5	HC5	195	HC	None			HC5	HC5		19006FL-11-01-02	Healthy controls	HC5		195	Yes				195	19006FL-11-01-02	good			https://ucsf.box.com/s/xg3hh58ob88w21h0nx10pjjfl9tc1vqo	yes	post-flow	3.0.2	v3	yes		5580	" 27,112.00 "	1469	"151,289,043"	90.6	90.3	49.4				78.7	23	1948	0	21.3	29.5	222
HC6	HC6	HC6	204	HC	None			HC6	HC6		19006FL-15-03-04	Healthy controls	HC6		204	Yes				204	19006FL-15-03-04	good			https://ucsf.box.com/s/ibr6ru5n9xuoc9mm3o4yc7vbhii5h29w	yes	post-flow	3.0.2	v3	yes		8661	" 20,603.00 "	"1,163"	"178,450,740"	89.60%	67.50%	42.10%				83.60%	52.70%	"2,827"	0	16.40%	65.30%	216
HC7	HC7	HC7	207	HC	None			HC7	HC7		19006FL-18-03-04	Healthy controls	HC7		207	Yes				207	19006FL-18-03-04	good			https://ucsf.box.com/s/rl1oy7kxo5kkip6jaf29p8v6k3m4xlju	yes	post-flow	3.0.2	v3	yes		7960	" 32,246.00 "	1341	"256,680,698"	91	85.1	59.3				57.9	28.1	1720	0	42.1	49.1	108
HC8	HC8	HC8	239	HC	None			HC8	HC8		19006FL-27-01-02-rerun-AH	Healthy controls	HC8		239	No	29718S			239	19006FL-27-01-02-rerun-AH	good	19006-37		https://ucsf.box.com/s/ig48r3909wgsb2prqsw0gchx8izeprcs	yes	post-flow	3.0.2	v3.1	yes		"9,149"	" 19,008.00 "	"1,126"	"173,905,686"	93.6	79.2	49.9				89.5	41.5	1414	0	10.5	46.8	141
HC9	HC9	HC9	242	HC	None			HC9	HC9		19006FL-28-03-04-NEW	Healthy controls	HC9		242	No	29718S			242	19006FL-28-03-04-NEW	good	33		https://ucsf.box.com/s/x4twq6do29d9dty71490mclhm2l1osg1	yes	post-flow	3.0.2	v3.1	yes		"4,453"	" 23,564.00 "	"1,271"	"104,934,147"	84	88.1	54.4				91.8	21.8	920	0	8.2	24	94
HC10	HC10	HC10	248	HC	None			HC10	HC10		19006FL-29-05-06-NEW AH	Healthy controls	HC10		248	No	29718S			248	19006FL-29-05-06-NEW AH	good	19006-33		https://ucsf.box.com/s/lzk6q8m2yfrwnhodrvuwlcg3njx6vyis	yes	post-flow	3.0.2	v3.1	yes		"7,137"	" 25,445.00 "	"1,189"	"181,605,077"	91	83.3	55.5				92.4	25.1	"1,888"	0	7.6	27.4	290
HC11	HC11	HC11	286	HC	None			HC11	HC11		19006FL-39-01-02-AH-20220820-with mouse transcriptome	Healthy controls	HC11		286	No	31078L			286	19006FL-39-01-02-AH-20220820-with mouse transcriptome	good			https://ucsf.box.com/s/qg0owj4z5se9un0eb53wkgwfqf1fb1lj	yes	post-flow	3.0.2	v3.1	yes		"7,598"	" 29,519.00 "	"1,460"	" 224,292,285 "	 94.7 	86.9	55.6				91.2	23.9	1549	0	8.8	26.5	175
S1-pre	P7	P7-Pre	234	PV	Pre	Partial	Non-responder	"P7 (277, 296): Non-responder"	P7 (234): Non-responder	Yes	19006FL-23-03-04	Psoriasis pre- and post-Tildrakizumab dataset	S1-pre1 (aka PV7)	pre (original)	234 (prob don't use for final analysis)	Yes				234	19006FL-23-03-04	good			https://ucsf.box.com/s/d0zqtul57dsm1fgv4ktb2709zcckcvk0	"yes, checked by JBC"	post-flow	3.0.2	v3			"1,653"	" 59,787.00 "	987	"98,829,545"	49.1	79	63.6				95.7	7.4	1815	0	4.3	7.9	237